The Official Website of the Long-Term Investor
Results 1 - 10 of 474 : 1 2 3 4 5 6 7 8 9 Next
The Dow's 3 Biggest Losers This Week
Here they are.
Bristol-Myers Squibb's Thud Heard Round the World
Bristol-Myers' dark ages have arrived as Plavix comes off patent.
5 Pharmaceutical Stocks With Significant Exposure to Europe
A fracture of the European monetary union could spell trouble for these five pharmaceutical stocks.
Will the FDA Approve Alexza's Adasuve?
Seems unlikely, given the data.
Maybe There Will Be Some Hep C Patients Left
Sales of Vertex's Incivek decline substantially.
Bristol-Myers Squibb Hits Estimates in Solid Quarter
Just the facts, Fool.
Celebrate the Hep C Wins, for Now
Good data in small packages.
Drug cocktails are the future of hepatitis C drugs.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK